Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 29,323 | 46,279 | 29,101 | 25,275 | 5,831 |
| Gross Profit | 29,323 | 46,279 | 29,101 | 25,275 | 5,831 |
| Operating Expenses | 63,244 | 73,436 | 59,932 | 39,869 | 28,590 |
| Operating Income | -33,921 | -27,157 | -30,831 | -14,594 | -22,759 |
| Interest Expense | 0 | 0 | 0 | -152 | -2 |
| Other Income | -3,145 | 1,688 | 3,765 | -2,102 | 120 |
| Pre-tax Income | -37,066 | -25,469 | -27,066 | -16,544 | -22,637 |
| Income Tax | 164 | N/A | -312 | 1,103 | 162 |
| Net Income Continuous | -37,230 | -25,469 | -26,754 | -17,647 | -22,799 |
| Net Income | $-37,230 | $-25,469 | $-26,754 | $-17,647 | $-22,799 |
| EPS Basic Total Ops | -54.40 | -44.80 | -40.00 | -32.00 | -44.00 |
| EPS Basic Continuous Ops | -54.67 | -40.25 | -40.32 | -32.14 | -43.73 |
| EPS Diluted Total Ops | -54.40 | -44.80 | -40.00 | -32.00 | -44.00 |
| EPS Diluted Continuous Ops | -54.67 | -40.25 | -40.32 | -32.14 | -43.73 |
| EPS Diluted Before Non-Recurring Items | -54.40 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-31,610 | $-26,525 | $-30,261 | $-14,225 | $-22,398 |